Nataliya Mar
9PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Aug 07, 2025
Comprehensive Comparison of Somatic, Germline, and Immune Cell Profiles in Upper Tract and Bladder Urothelial Carcinoma.Kit Yuen, Margaret Meagher, Jacob Mercer
|Jan 12, 2024
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab.Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes
|Jul 04, 2023
Drug extravasation with Enfortumab vedotin.Christopher Ryan Grant, Dimitri de Kouchkovsky, Arash Rezazadeh Kalebasty
|Jun 27, 2023
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer.Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak
|Jan 19, 2022
Use of enfortumab vedotin in an HIV-positive patient with urothelial carcinoma.Armon Azizi, Roozbeh Houshyar, Nataliya Mar
|Sep 22, 2021
Renal Cell Carcinoma-Lessons in Diversity, Breakthroughs, and Challenges.Nataliya Mar, Dalia Kaakour, Arash Rezazadeh Kalebasty
Pageof 2
Frequent Collaborators
3 joint publications
Rana R McKay
2 joint publications
Arash Rezazadeh Kalebasty
2 joint publications
Anne-Sophie Carret
2 joint publications
Matthew I Milowsky
2 joint publications
Daniel P Petrylak
2 joint publications
Christopher J Hoimes
2 joint publications
Thomas W Flaig
2 joint publications
Terence W Friedlander
2 joint publications
Sergio Bracarda
2 joint publications
Chethan Ramamurthy
